Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide
- PMID: 16365736
- DOI: 10.1007/s00417-005-0208-z
Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide
Abstract
Background: To report on procedure-related anterior segment complications during intravitreal injections.
Methods: In a prospective interventional case series, 614 eyes received a total of 723 intravitreal injections of about 20 mg triamcinolone acetonide (in 0.2 ml) after paracentesis and aqueous humor drainage for various indications.
Results: In three eyes (0.49% of all eyes) a vitreous prolapse occurred during the injection. In one eye, the vitreous prolapse was combined with dislocation of the intraocular lens (IOL). All three eyes were pseudophakic, showing an posterior capsule defect, and the IOL located in the ciliary sulcus. They were treated by translimbal vitrectomy, and one eye with reposition of the IOL. No other procedure-related postoperative complications were observed during injection or follow-up (7.8+/-7.1 months).
Conclusions: Intravitreal injections may cause a vitreous prolapse into the anterior chamber with or without IOL decentration or dislocation in predisposed eyes. Ophthalmologists should be aware of this possible complication and inform patients at risk.
Similar articles
-
Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models.Acta Ophthalmol. 2008 Feb;86(1):97-102. doi: 10.1111/j.1600-0420.2007.01058.x. Epub 2007 Oct 1. Acta Ophthalmol. 2008. PMID: 17908254
-
Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery.Am J Ophthalmol. 2004 Oct;138(4):650-2. doi: 10.1016/j.ajo.2004.05.033. Am J Ophthalmol. 2004. PMID: 15488797
-
Experimental use of estriol for visualizing the vitreous body in the anterior chamber after posterior capsule rupture in animal models.J Cataract Refract Surg. 2009 Jul;35(7):1260-5. doi: 10.1016/j.jcrs.2009.02.022. J Cataract Refract Surg. 2009. PMID: 19545818
-
Intravitreal triamcinolone acetonide: a change in a paradigm.Ophthalmic Res. 2006;38(4):218-45. doi: 10.1159/000093796. Epub 2006 Jun 6. Ophthalmic Res. 2006. PMID: 16763379 Review.
-
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x. Acta Ophthalmol Scand. 2005. PMID: 16396641 Review.
Cited by
-
Low-fluence-rate photodynamic therapy to treat subfoveal choroidal neovascularization in pathological myopia. A study of efficacy and safety.Graefes Arch Clin Exp Ophthalmol. 2010 Apr;248(4):497-502. doi: 10.1007/s00417-009-1232-1. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 19916015
-
Efficacy of Large Optic Intraocular Lenses in Myopic Eyes with Posterior Segment Pathology.Ophthalmol Ther. 2022 Feb;11(1):443-452. doi: 10.1007/s40123-021-00433-3. Epub 2021 Nov 27. Ophthalmol Ther. 2022. PMID: 34843086 Free PMC article.
-
Neodymium: yttrium-aluminum-garnet laser anterior hyaloidotomy to treat trapped triamcinolone acetonide behind the crystalline lens after intravitreal injection.Middle East Afr J Ophthalmol. 2012 Jan;19(1):163-5. doi: 10.4103/0974-9233.92135. Middle East Afr J Ophthalmol. 2012. PMID: 22346134 Free PMC article.
-
Posterior lens nucleus displacement following intravitreal injection.Eye (Lond). 2013 Sep;27(9):1103-4. doi: 10.1038/eye.2013.140. Epub 2013 Jun 28. Eye (Lond). 2013. PMID: 23807382 Free PMC article. No abstract available.
-
Entrapment of intravitreal triamcinolone behind the crystalline lens.Indian J Ophthalmol. 2009 Jul-Aug;57(4):324-5. doi: 10.4103/0301-4738.53066. Indian J Ophthalmol. 2009. PMID: 19574709 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical